Eli Lilly Invests $6.3 Billion on Sleep Science with Centessa Pharmaceuticals Acquisition

Eli Lilly (NYSE: LLY) is making one of its boldest neuroscience moves yet, announcing a definitive agreement to acquire clinical-stage biotech Centessa Pharmaceuticals (Nasdaq: CNTA) in a deal valued at up to $47.00 per share — representing a total potential equity value approaching $7.8 billion when contingent payments are included.

The upfront cash consideration of $38.00 per share reflects an aggregate equity value of approximately $6.3 billion and carries a 40.5% premium to Centessa’s 30-day volume-weighted average trading price ended March 30, 2026. Shareholders will also receive one non-transferable contingent value right (CVR) worth up to an additional $9.00 per share, tied to three FDA approval milestones for Centessa’s lead drug candidates.

What Lilly Is Really Buying

The deal is fundamentally about orexin receptor 2 (OX2R) science — a mechanism that sits at the neurobiological center of how the brain regulates the sleep-wake cycle. Centessa has spent years building what it believes is a potential best-in-class pipeline of OX2R agonists, with its lead candidate cleminorexton (formerly ORX750) having already shown promising Phase 2a clinical data across three major sleep disorders: narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia.

Beyond cleminorexton, Centessa’s portfolio includes additional clinical and preclinical-stage assets targeting neurological, neurodegenerative, and neuropsychiatric indications — giving Lilly a broader platform than a single drug acquisition would suggest.

The CVR Structure

The contingent value rights break down as follows: $2.00 per CVR upon FDA approval of cleminorexton or ORX142 for narcolepsy type 2 before the fifth anniversary of close; $5.00 per CVR upon FDA approval for idiopathic hypersomnia within the same window; and $2.00 per CVR upon the first FDA approval of either candidate for any indication before January 1, 2030.

CVR structures are increasingly common in biopharma M&A as a tool to bridge valuation gaps between buyers and sellers when clinical outcomes remain uncertain. For Centessa shareholders, the arrangement means meaningful upside if the pipeline delivers — but no guarantees.

Strategic Fit and Timing

The acquisition lands at a moment when sleep disorder therapeutics are gaining serious commercial momentum. The emergence of orexin-based therapies — like Idorsia’s daridorexant and Eisai and Biogen’s lemborexant — has validated the mechanism on the wake-promotion side of the equation. Centessa’s OX2R agonist approach works in the opposite direction, promoting wakefulness rather than suppressing it, which addresses a different and underserved patient population.

For Lilly, a company already navigating massive commercial demands from its GLP-1 and Alzheimer’s franchises, adding a differentiated neuroscience platform signals a commitment to diversifying its long-range pipeline.

The transaction is structured as a scheme of arrangement under English and Welsh law and is expected to close in the third quarter of 2026, pending Centessa shareholder approval, High Court sanction, and customary regulatory clearances. Approximately 24.1% of Centessa’s outstanding shares are already locked up through voting and support agreements signed by major investors including Medicxi Ventures, Index Ventures, and General Atlantic.

Unicycive Therapeutics (UNCY) – FY2025 Loss Reported With OLC PDUFA Data Approaching


Tuesday, March 31, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

NDA Sumisssion Was Accepted In January. Unicycive reported loss for FYQ25 of $26.6 million or $(1.67) per share. Importantly, the resubmission of the NDA for oxylanthanum calcium (OLC), its phosphate binder for controlling high phosphate levels in renal dialysis patients, was accepted for filing by the FDA. The PDUFA data is June 19, 2026. Cash on December 31, 2026 was $54.9 million, which we estimate is sufficient to last through product launch and the first quarter of OLC sales.

We Believe Previous Issues Have Been Settled. The NDA was submitted in December 2025 and accepted for filing in January. FDA acceptance and notification of the PDUFA date signifies that the application is complete for review. There were no questions about the third-party manufacturing issue that stopped the review process in June 2025. We believe the corrective actions have addressed the problem, allowing for marketing approval by June 2026.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Release – SEGG Media Aligns Leadership to Drive Revenue Execution and Growth

Research News and Market Data on SEGG

March 30, 2026

PDF Version

FORT WORTH, Texas, March 30, 2026 (GLOBE NEWSWIRE) — Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG, LTRYW) (the “Company” or “SEGG Media”), the global sports, entertainment, and gaming group, today announced the appointments of Veloce executives Daniel Bailey as Chief Commercial Officer and Jack Clarke as Chief Strategy Officer, further strengthening our leadership team as SEGG Media moves forward in its strategic growth phase.

After completing the Veloce acquisition and materially increasing the Company’s revenue, these appointments have been made to further support SEGG Media’s 90-day plan focused on execution, integrating operations and teams, and monetizing new assets.

Operators with Proven Track Records

Daniel Bailey, Chief Commercial Officer, brings over a decade of experience in motorsport and global sports commercial strategy, having delivered $53+ million in commercial partnerships and revenue.

Mr. Bailey played a key role in scaling Veloce Media Group, including structuring the acquisition of Quadrant and securing a series of multi-million-pound funding rounds. His experience includes partnerships with global blue-chip brands and rights holders including Formula 1, VISA, Ferrari, McLaren, Mercedes, E.ON, Tencent, Sotheby’s, and Deutsche Bank.

Previously, Mr. Bailey led commercial efforts at IMG Motorsports and co-founded MPA Creative, an award-winning PR, marketing, and events agency, where he remains an active Director. MPA was named 2026 Boutique Agency of the Year at the Race Media Awards.

As Chief Commercial Officer, Mr. Bailey will lead SEGG Media’s global monetization strategy, focused on revenue growth, partnerships, and value creation across the Company’s digital ecosystem.

Jack Clarke, Chief Strategy Officer, combines elite sporting experience with high-growth media entrepreneurship. A former professional racing driver with wins and podiums in FIA Formula 2, he transitioned into business in 2015.

After roles in a sports technology investment fund and IMG, Mr. Clarke co-founded Veloce Media Group, helping build one of the fastest-growing digital motorsport and gaming media platforms globally. He played a key role in scaling Veloce’s esports operations and growing its media network to over 600 million monthly views – shaping commercial and strategic direction from inception, and driving innovation across content, partnerships, and revenue models.

As Chief Strategy Officer, Mr. Clarke will focus on enterprise strategy, capital discipline, and integration execution to ensure acquisitions translate into scalable revenue and long-term shareholder value.

Marc Bircham, Chairman of SEGG Media, commented: “We are aligning leadership for execution to deliver the results expected of us by our shareholders. Dan and Jack are operators who have built, scaled, and monetized platforms globally.”

Robert Stubblefield, Chief Financial Officer and Interim President and CEO, added: “Dan and Jack bring a rare combination of strategic discipline and commercial firepower. Their experience in scaling Veloce and delivering real revenue growth directly aligns with our priorities. We believe this significantly strengthens our ability to execute and deliver value that is not yet reflected in the market.”

Positioned for Near-Term Revenue Expansion

SEGG Media’s current initiatives are expected to:

  • Expand revenue through maximizing the potential of high-growth digital and media assets
  • Accelerate monetization for Sports.com, Concerts.com, and TicketStub.com
  • Unlock operating efficiencies through integration and scale
  • Improve financial visibility as execution milestones for revenue growth are achieved

Disciplined Strategy, High-Impact Execution

SEGG Media continues to prioritize fiscal and operating discipline and high-return initiatives, focusing on:

  • Near-term revenue generation
  • Minimizing shareholder dilution
  • Clear, measurable achievement that results in creating shareholder value

About SEGG Media Corporation

Sports Entertainment Gaming Global Corporation (Nasdaq: SEGG, LTRYW) is a global sports, entertainment, and gaming group operating a portfolio of digital and experiential assets including Sports.com, Concerts.com, TicketStub.com, Lottery.com, and Veloce Media Group. Through its expanding ecosystem of media, live experiences, gaming platforms, and creator-led content, the Company connects global audiences to the sports, events, and interactive entertainment they love. Focused on disciplined execution, ethical gaming, and scalable revenue generation, SEGG Media is building an integrated platform designed to drive sustainable growth and long-term shareholder value.

Important Notice Regarding Forward-Looking Statements 

This press release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this press release, regarding the Company’s strategy, future operations, prospects, plans and objectives of management, are forward-looking statements. When used in this Form 8-K, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” “initiatives,” “continue,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. The forward-looking statements speak only as of the date of this press release or as of the date they are made. The Company cautions you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. In addition, the Company cautions you that the forward-looking statements contained in this press release are subject to risks and uncertainties, including but not limited to, any future findings from ongoing review of the Company’s internal accounting controls, additional examination of the preliminary conclusions of such review, the Company’s ability to secure additional capital resources, the Company’s ability to continue as a going concern, the Company’s ability to respond in a timely and satisfactory matter to the inquiries by Nasdaq, the Company’s ability to regain compliance with the Bid Price Requirement, the Company’s ability to regain compliance with Nasdaq Listing Rules, the Company’s ability to become current with its SEC reports, and those additional risks and uncertainties discussed under the heading “Risk Factors” in the Form 10-K/A filed by the Company with the SEC on April 22, 2025, and the other documents filed, or to be filed, by the Company with the SEC. Additional information concerning these and other factors that may impact the operations and projections discussed herein can be found in the reports that the Company has filed and will file from time to time with the SEC. These SEC filings are available publicly on the SEC’s website at www.sec.gov. Should one or more of the risks or uncertainties described in this press release materialize or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release.

This press release was published by a CLEAR® Verified individual.

For additional information, visit www.seggmedia.com or contact media relations at [email protected].

Iran’s Fifth Week: The Domino That Could Send Oil Prices Into Uncharted Territory

Oil markets opened the week in full crisis mode — and two developments over the weekend made clear that this conflict is far from finding a ceiling.

Brent crude traded near $108 per barrel Monday morning while WTI crossed $102, each up roughly 3% on the session and more than 70% above where they started the year. The war in Iran is now in its fifth week, and the supply picture just got significantly more complicated.

A Second Chokepoint Enters the Picture

The Strait of Hormuz has been effectively closed since early March, stripping roughly 20% of global oil and LNG supply from world markets in a single stroke. Saudi Arabia’s East-West Pipeline — the only meaningful rerouting option — is already running at its full capacity of 7 million barrels per day with zero room to expand.

Now a second chokepoint is under direct threat. Iran-backed Houthi militants in Yemen are positioning to disrupt the Bab el-Mandeb Strait — the narrow passage between Yemen and Djibouti that connects the Red Sea to the Gulf of Aden. Every westbound oil tanker that escapes Hormuz via Saudi Arabia’s pipeline must still transit this corridor to reach European and Atlantic markets. Insurance costs for Red Sea routes are climbing sharply and shipowners are already pulling back.

If the Bab el-Mandeb is closed, the market loses another estimated 7 million barrels per day — stacked on top of the 15 million already offline. That math would represent the most severe supply disruption in recorded energy history, eclipsing the 1973 oil shock in scale and speed.

Washington Raises the Stakes

The second driver of Monday’s move came from the White House. President Trump renewed explicit threats to destroy Iran’s oil infrastructure, power generation plants, and desalination facilities if a deal is not reached imminently. The U.S. now has approximately 50,000 troops deployed to the Gulf, including elite rapid-entry units. A Wall Street Journal report Sunday evening added that the administration is weighing a special operations mission to extract uranium from Iran’s underground nuclear compounds — a scenario that analysts broadly view as an immediate and severe escalation trigger.

Treasury Secretary Bessent offered a partial offset, hinting at potential U.S. or multinational naval escorts to restore navigation through the straits — which briefly pulled futures off their highs at Monday’s open. But the underlying tension held. Iran has continued to insist it is not in active negotiations, even as Trump has claimed “great progress” toward a deal.

JPMorgan’s commodities strategy team, led by Natasha Kaneva, wrote Sunday that markets are still underestimating the downside risks. The concern, they noted, is no longer whether this escalates further — it’s when.

The Broader Market Fallout

The energy crisis is metastasizing beyond the oil patch. European gas storage entered this conflict at historically low levels — roughly 30% capacity — after a harsh winter. Dutch TTF gas benchmarks have nearly doubled since hostilities began. Chemical and steel manufacturers across the UK and EU have imposed surcharges of up to 30% to offset surging input costs. The ECB has already postponed planned rate cuts and revised its inflation forecasts higher.

The International Energy Agency announced what would be the largest strategic petroleum reserve release in its history — 400 million barrels — as a near-term stabilizer. It addresses the pressure but not the cause. With two chokepoints now in play, no diplomatic resolution on the table, and 50,000 U.S. troops in the region, the structural bid under oil prices isn’t dissipating this week.

The energy industry’s own assessment is blunt: this may only be the beginning of the supply shock, not the peak of it.

Release – Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update

Research News and Market Data on UNCY

March 30, 2026 7:05am EDT Download as PDF

  • Oxylanthanum carbonate (OLC) New Drug Application (NDA) resubmission under review by U.S. Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) target action date of June 29, 2026
  • Commercial readiness activities ongoing in anticipation of potential commercial launch of OLC in 3Q26
  • As of March 30, 2026 unaudited cash, cash equivalents, and marketable securities totaled $54.9 million, with expected runway into 2027

LOS ALTOS, Calif., March 30, 2026 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the full year ended December 31, 2025, and provided a business update.

“This year is shaping up to be pivotal for Unicycive, underscored by the U.S. Food and Drug Administration’s acceptance of our New Drug Application resubmission for OLC and the potential for approval and launch later this year,” said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. “With hyperphosphatemia still uncontrolled in nearly 75% of U.S. patients with chronic kidney disease undergoing dialysis, OLC, if approved, has the potential to offer a meaningful new treatment option characterized by a differentiated clinical profile and reduced pill burden compared to currently available phosphate binders.”

Key Highlights & Upcoming Milestones

  • In January 2026, the Company announced the FDA has accepted the resubmission of its NDA for OLC, an investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a PDUFA target action date of June 29, 2026. The NDA is supported by data from three clinical studies (a Phase 1 study in healthy volunteers, a bioequivalence study in healthy volunteers and a tolerability study in patients with CKD on dialysis), multiple preclinical studies and chemistry, manufacturing and controls (CMC) data. The FDA did not raise any concerns regarding the preclinical, clinical or safety data for OLC included in the original NDA submission. The resubmission in December 2025 was based on the progress made by the third-party manufacturing vendor responsible for the drug product (Drug Product).
  • As part of Unicycive’s continued preparation to support a potential launch of OLC later this year, the Company is continuing to strengthen its commercial infrastructure and advance market readiness initiatives.

Financial Results for the Year Ended December 31, 2025

Research and Development (R&D) expenses were $9.1 million for the year ended December 31, 2025, compared to $20.0 million for the same period in 2024. The decrease in research and development expenses was primarily due to a decrease in drug development as well as clinical trial costs.

General and Administrative (G&A) expenses were $20.4 million for the year ended December 31, 2025, compared to $12.1 million for the same period in 2024. The increase was primarily due to an increase in consulting, professional services, and commercial launch preparation costs.

Other income was $3.0 million for the year ended December 31, 2025 compared to Other expense of $4.6 million in the same period in 2024 due primarily to a decrease in the fair value of the Company’s warrant liability.

Net loss attributable to common stockholders for the year ended December 31, 2025 was $26.6 million, or $1.67 per share of common stock, compared to a net loss attributable to common stockholders of $37.8 million, or $5.65 per share of common stock for the same period in 2024. The decreased net loss for the year ended December 31, 2025, was attributable primarily to the decrease in drug development and clinical trial costs.

As of March 30, 2026 unaudited cash, cash equivalents, and marketable securities totaled $54.9 million. The Company believes that it has sufficient resources to fund planned operations into 2027.

About Unicycive Therapeutics

Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit Unicycive.com and follow us on LinkedIn and X.

Forward-looking statements

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified using words such as “anticipate,” “believe,” “forecast,” “estimated” and “intend” or other similar terms or expressions that concern Unicycive’s expectations, strategy, plans or intentions. These forward-looking statements are based on Unicycive’s current expectations and actual results could differ materially. There are several factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, clinical trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results; our clinical trials may be suspended or discontinued due to unexpected side effects or other safety risks that could preclude approval of our product candidates; our dependence on third parties for manufacturing; risks related to business interruptions, which could seriously harm our financial condition and increase our costs and expenses; dependence on key personnel; substantial competition; uncertainties of patent protection and litigation; dependence upon third parties; market acceptance of our products; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled ‘Risk Factors’ in Unicycive’s Annual Report on Form 10-K for the year ended December 31, 2025, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Unicycive specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Contacts:

Kevin Gardner
LifeSci Advisors
[email protected]

Media Contact:

Layne Litsinger
Real Chemistry
[email protected]

SOURCE: Unicycive Therapeutics, Inc.

View full release here.

FreightCar America (RAIL) – Updating Estimates; Rating Remains an Outperform


Monday, March 30, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Updating estimates. We revised our FY 2026 estimates to reflect lower margins in the first and second quarters. While our full year revenue, EBITDA, and EPS estimates are unchanged, the quarterly allocations have shifted. We forecast first quarter revenue, EBITDA, and EPS of $86.0 million, $7.0 million, and $0.04, respectively, compared to our prior estimates of $89.0 million, $8.8 million, and $0.08. We have assumed growing Aftermarket segment revenue throughout the year. Our FY 2026 revenue, EBITDA, and EPS estimates remain $525.0 million, $44.5 million, and $0.54, respectively. 

Lowering 1H’ 2026 expectations. We think the first quarter of 2026 will reflect the fewest deliveries during the year, along with a less favorable product mix. Accordingly, we expect 2026 deliveries, revenue, and earnings to be weighted toward the second half of the year, supported by higher volumes, an improved product mix, and increased contributions from new builds and retrofit programs.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

The Market Is Speaking in Two Languages Today — and Both Matter

Monday’s session delivered one of the cleanest market splits in recent weeks — energy surging, semiconductors cratering, and the major indexes going their separate ways as Wall Street entered a holiday-shortened trading week with no shortage of unresolved questions.

The Dow Jones added roughly 0.3% while the S&P 500 slipped 0.7% and the Nasdaq dropped nearly 1.1% by afternoon trading. Both the Dow and Nasdaq are now in correction territory following last week’s close. The divergence wasn’t noise — it reflected two very real and competing forces battling for the market’s direction.

The Chip Selloff Has a New Villain

Micron led semiconductor stocks sharply lower on Monday, falling more than 10% in afternoon trading. Sandisk shed 8%, Intel dropped 4%, AMD fell close to 3%, and Nvidia gave back roughly 1%. The across-the-board weakness extended a sell-off that began last week and found fresh fuel over the weekend.

The catalyst is a Google algorithm called TurboQuant, announced last week, which allows AI models to run more efficiently by cutting the amount of memory required. The implications for memory chip demand — and pricing — are exactly what the market is now attempting to price in. If AI workloads require meaningfully less memory bandwidth to operate, the demand thesis underpinning names like Micron gets complicated fast.

The debate is far from settled. Experts argue that memory chip pricing could stay firm through 2027, pointing to continued strength in AI data center demand with no signs of a slowdown and supply conditions tight enough to drive price inflation in several chip categories. That’s a reasonable counter — but on a Monday in a correction, the market is choosing the bearish read first and asking questions later.

Oil Doesn’t Care About Algorithms

On the other side of the ledger, crude had another strong session. Brent held above $107 per barrel and WTI crossed $103 as the Iran conflict continued to dominate commodity markets. President Trump added fresh fuel Monday, telling the Financial Times that his preference is for the U.S. to control Iran’s oil industry indefinitely — language that signals the conflict’s resolution is not imminent and that supply disruptions through the Strait of Hormuz and now the Bab el-Mandeb Strait could persist for weeks or months.

Energy was the one sector that didn’t need to rationalize its rally today. The math is straightforward: supply is constrained, no deal is in sight, and $100+ oil is becoming the baseline assumption rather than the shock scenario.

Eyes on the Week Ahead

With Friday’s session closed for Good Friday, this is a compressed week with outsized data. JOLTS, ADP private payrolls, and the March jobs report all land before the long weekend — and after the January-February whipsaw in employment numbers, each print carries extra weight. Nike’s earnings will offer a read on consumer health that the macro data alone can’t provide.

The setup: a market digesting a genuine technology disruption narrative while simultaneously pricing in the worst energy crisis in a generation. That’s not a market that moves in one direction.

Consumer Sentiment Just Hit a 3-Month Low

The American consumer is starting to crack, and the timing could not be worse for small-cap companies heading into earnings season.

The University of Michigan’s Index of Consumer Sentiment closed March at a final reading of 53.3 — below the 54 economists had forecast, down 5.8% from February, and the lowest reading since December. The drop was broad-based, cutting across all age groups and political affiliations, and it arrived just as small-cap stocks were already absorbing a brutal month of rising yields, a stalled rate-cut timeline, and a commodity shock with no clear end in sight.

The culprits are familiar by now: surging gas prices and stock market volatility tied directly to the Iran conflict. With the Strait of Hormuz still largely blocked and Brent crude trading above $110 per barrel, gas prices have risen more than $1 on average over the past month alone, according to AAA. That kind of increase hits consumers immediately and visibly — every fill-up is a reminder that something is wrong — and it has a well-documented drag on discretionary spending.

For small-cap companies, weakening consumer sentiment is not an abstract concern. These businesses — regional retailers, restaurant operators, consumer services companies, domestic manufacturers — are more directly exposed to shifts in consumer behavior than their large-cap counterparts, and they have fewer tools to manage the fallout. They can’t absorb margin compression as long, can’t hedge as efficiently, and don’t have the brand loyalty or pricing power that insulates household names from demand slowdowns.

The inflation expectations embedded in Friday’s data make the picture more complicated. Year-ahead inflation forecasts jumped to 3.8% from 3.4% in February — the largest single-month increase since April 2025, when sweeping global tariffs rattled markets. Long-term inflation expectations came in at 3.2%, still well above the pre-pandemic baseline. When consumers believe inflation is sticky, they pull back on big-ticket discretionary purchases and shift spending toward necessities. That behavioral shift flows directly into the revenue lines of the small-cap consumer sector.

There’s another dimension here that matters specifically to small-cap investors. Middle- and higher-income households reported some of the sharpest drops in sentiment this month, driven in part by stock market losses. With equity exposure now accounting for nearly 40% of household net worth — more than double its share during the oil shocks of the 1990s — market volatility has a faster and deeper psychological impact on consumer behavior than it did in previous energy crises. When portfolios fall, confidence follows, and discretionary spending follows confidence.

The S&P 500 is down 6.5% over the past month. The Dow is off 6.8%. The Russell 2000 has been even harder hit, entering correction territory earlier this month as the combination of higher-for-longer rates, a debt maturity wall, and energy-driven inflation converged at the worst possible time.

Consumer sentiment had been gradually recovering before March’s reversal, which means this isn’t a continuation of a trend — it’s a break in one. Whether it stabilizes or deteriorates further depends almost entirely on how long the Iran conflict persists and whether gas prices begin to pull back. Until there’s clarity on the Strait of Hormuz, small-cap consumer-facing companies should be approached with caution heading into Q1 earnings.

The data is speaking. The question is whether the market is listening.

Release – NN Announces Acquisition to Further Growth in Electric Grid and Data Center

Research News and Market Data on NNBR

PDF Version

CHARLOTTE, N.C., March 27, 2026 (GLOBE NEWSWIRE) — NN, Inc. (“NN” or the “Company”) (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies with six sigma quality today announced that it has acquired the large-scale automated plating operations from a leading global provider of electrical infrastructure solutions. This seller is an existing customer which is moving from in-house manufacturing to outsourced operations with this decision.

The equipment acquisition will enable NN to significantly expand its processing capabilities in silver-plated busbars and terminals among other capabilities, which are ideal electrical components for electric grid and data center equipment. This further enables NN to broaden its market aperture on growth in this area, its second largest end market.

The plating line being acquired is substantially larger and more automated than NN’s current capabilities, featuring large plating baths designed for high-volume, low-cost production. The automated plating line will enable NN to process larger parts representing a transformative expansion of its product offering in terms of size, volume, and type of plated metal products that NN will be able to deliver to its electrical customers.

NN expects this new capability to be operational at an existing facility in the fall of 2026. Financially, the new business won from this line will be inclusive to the Company’s prior guidance of $70 million to $80 million of new business wins in 2026. The capex associated with this project is inclusive to the company’s capex guidance of $20 million to $22 million in 2026. The Company is funding this strategic addition from operating cash flow.

The key end markets that will be targeted with this new capability are electric grid equipment and data center equipment. The Company is initially focused on switchgear assemblies used in emergency power generation for the grid, hospitals, and data centers.

Harold Bevis, President and Chief Executive Officer of NN, Inc., commented, “This equipment acquisition is another stepping stone for NN’s strategic pivot into certain high-value verticals that fit its operational footprint. We are adding capabilities that open up the aperture for growth in the target markets of electric grid and data center. Our plating business is known in the industry as GMF and is one of the highest gross margin plants in the NN portfolio. This is accretive business for NN. The return on investment is consistent with the ROIs that we target for new business.”

Bevis continued, “This is precisely the type of high-value, capital-efficient growth opportunity that we are focused on securing as we execute our sales growth plan. GMF has a strong reputation for quality, on-time delivery, and deep expertise in the science of electroplating. This business is key to growth in electronics, defense, electric grid, and data center. This equipment is a logical addition to our capabilities and will unlock our prospecting into larger parts, higher volume parts, bigger programs, and more customers. The equipment was acquired from a long-term NN customer, that intends to repurpose its reclaimed floor space as data center and grid infrastructure markets take off, so this is a win-win for all parties.”

“This acquisition is consistent with NN’s broader strategic transformation plan, which has already delivered three consecutive years of improved adjusted EBITDA. The Company has exited dilutive, lower-value business and is actively replacing that rationalized volume with higher-margin, accretive new growth through engineering-led new products and new program wins. NN has secured more than $200 million of new awards from its technology-based new business development program, and NN expects to launch approximately 100 awarded programs during 2026. Launched in mid-2023 under new management, the new business program is focused on leveraging the Company’s technology and operational footprint strengths into new areas. The Company is guiding to a fourth consecutive year of improved adjusted EBITDA and a materially higher amount of operating cash flow.”

Bevis continued, “NN has a couple of other small acquisitions that we are focused upon and have been working on for about a year. They are also focused on non-automotive, high-value capability expansion and profitable growth. Over the last two years most of our operating cash flow was consumed by four plant closures and severing about 800 people, which was tough and brutal for those impacted but necessary for NN’s transition.

We have turned the page onto a new chapter and have a balanced approach to our revenue growth and repositioning. We are pursuing a few target markets that require safety critical features on linchpin metal parts and assemblies. We are extremely committed to a common engineering and manufacturing platform that can deliver value-added metal part solutions in several safety-critical end markets that offer high margins due to delivering high value. These include:

  • High-value auto parts – our #1 end market
  • Electric grid and data center parts – our #2 market, on a plan to become our #1 market
  • Defense, weapons, and electronic parts
  • Medical equipment parts

Bevis concluded, “We are intentionally pricing higher on low-value, low-margin business like commodity auto. Where we can, we are repurposing existing equipment, but when we must buy new equipment, we are doing so. We do not keep these kinds of records but 2026 will probably be the most amount of new equipment installed in our company. And it is all pre-loaded with new awards. The key enablers in our success are our engineering skills and our trade secrets regarding making metals deliver exceptional functionality at scale. This is code for world-class six sigma quality processes designed around error-proof, fail-proof design-for-manufacturability. We do this through our own knowledge, co-development with our customers, and emerging AI assistance. 2026 is shaping up to be a fun year focused upon engineering-driven revenue growth.”

ABOUT GMF

GMF has supported high-reliability programs across defense, aerospace, medical, and industrial markets for more than 50 years. The division provides manual rack, barrel, and vibratory plating, stainless steel electropolishing, and a broad range of precious and non-precious metal finishes that meet stringent military and commercial specifications. GMF holds NADCAP accreditation, ISO 13485:2016, and ISO 9001:2015 certifications, and processes millions of parts annually across more than 50,000 square feet of production space. The division is noted for its reputation in high-quality production, on-time delivery, and a 50% hit rate on quoted new business, which is well above industry averages. For more information, please visit www.genmetal.com.

ABOUT NN

NN, Inc., a global diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has facilities in North America, Europe, South America, and China. For more information about the Company and its products, please visit www.nninc.com.

Forward-Looking Statements

This press release contains express and implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding NN’s pursuit of new end markets, NN’s competitive position in the data center market, the success of NN’s investments to meet the requirements of awarded business, and expected new business wins for 2026 and other statements that are not historical facts. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “growth,” “guidance,” “intend,” “may,” “will,” “possible,” “potential,” “predict,” “project”, “trajectory” or other similar words, phrases or expressions. Forward-looking statements involve a number of risks and uncertainties that are outside of management’s control and that may cause actual results to be materially different from such statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector; material changes in the costs and availability of raw materials; the level of our indebtedness; our ability to secure, maintain or enforce patents or other appropriate protections for our intellectual property; and cyber liability or potential liability for breaches of our or our service providers’ information technology systems or business operations disruptions. The foregoing factors should not be construed as exhaustive and should be read in conjunction with the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s filings made with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. New risks and uncertainties may emerge from time to time, and it is not possible for the Company to predict their occurrence or how they will affect the Company. The Company qualifies all forward-looking statements by these cautionary statements.

Investor Relations: 
Joseph Caminiti or Abe Plimpton
[email protected]  
312-445-2870 

Primary Logo

Source: NN, Inc.

$110 Oil and a Blocked Strait: The Iran Shock Is Now Splitting Small-Cap Stocks in Two

The Iran war didn’t just push Brent crude past $100 a barrel — it drew a sharp line through the small-cap market, separating companies that are printing cash from those quietly bleeding out. One month in, that divide just got wider.

Brent crude surged 2.82% to $111.06 per barrel on Friday after two ultra-large container vessels owned by China Ocean Shipping Company — COSCO, the world’s fourth-largest shipping line by capacity — attempted to transit the Strait of Hormuz and were turned back. The incident carries significant weight: China is an ally of Iran, and Tehran had previously signaled that friendly nations’ ships could pass freely. The fact that even Chinese vessels are being blocked signals that Iran’s chokehold on the waterway remains firmly in place, despite diplomatic noise suggesting otherwise.

Iran controls access to a strait that handles roughly 20% of the world’s daily oil supply. Since the U.S.-Israeli strikes began on February 28, close to 500 million barrels of total liquids have been lost, with approximately 17.8 million barrels per day of oil and fuel flows disrupted, according to Rystad Energy. WTI, meanwhile, climbed to $97.01 on Friday — up from roughly $65 in February. The buffer that kept prices from going completely vertical is now gone. Rystad’s chief oil analyst described the global supply system as having shifted from “buffered to fragile,” with inventories drawn down to a point where there is little room left to absorb further shocks.

President Trump announced a 10-day pause on strikes targeting Iran’s energy infrastructure through April 6, and said talks were progressing — but markets barely reacted. The COSCO incident hit the same day, effectively negating any diplomatic optimism. Iran also reportedly allowed 10 oil tankers to pass through the strait this week as a goodwill gesture, but analysts were quick to caution that isolated shipments do not signal a reopening.

The Winners: Domestic Producers and LNG Players

The clearest beneficiaries are U.S.-based exploration and production companies with no Middle East operational exposure. They’re capturing elevated prices without the liability of stranded tankers, damaged facilities, or rerouting costs eating into the margins of globally integrated operators.

Small- and mid-cap names like Antero Resources (AR), Solaris Energy Infrastructure (SEI), and SM Energy (SM) have all been flagged by analysts as well-positioned to benefit from both higher prices and the scramble among European and Asian buyers to replace Persian Gulf supply. Antero in particular benefits from the LNG export surge — Asian LNG prices have skyrocketed more than 140% since the war began as Qatar halted exports, and U.S. natural gas producers with export exposure are capturing that spread directly. The SPDR S&P Oil & Gas Exploration & Production ETF (XOP) is up roughly 10% since the conflict started, significantly outpacing the broader market.

The Losers: Everyone Paying the Energy Tax

For small-cap companies outside the energy sector, $110 oil is a cost, not a catalyst. Airlines, regional manufacturers, consumer discretionary companies, and logistics-heavy businesses are absorbing higher input costs with limited pricing power and thin margins. Unlike large-caps with robust balance sheets, smaller companies can’t easily hedge energy exposure or wait out a prolonged commodity spike.

The macro backdrop makes it worse. The Russell 2000 entered correction territory this month and the timing is brutal. Approximately 32% of the debt held by Russell 2000 companies is floating-rate, meaning every basis point that rate-cut expectations get pushed back translates directly into higher interest expenses. With the Fed holding rates steady at its March 18 meeting and revising its inflation outlook higher, the one rate cut markets were pricing in for late 2026 is increasingly in doubt. Small-cap firms are facing approximately $368 billion in debt maturing in 2026 alone, much of it originally issued at near-zero rates — now needing to be refinanced at 6.5% to 8%.

Bank of America has noted that small caps with oil exposure but limited refinancing risk may be best positioned in the current environment. That framing is the right lens heading into Q1 earnings. The question isn’t whether oil stays at $110. It’s whether your small-cap holdings are collecting the windfall or paying the price for it — and with the Strait of Hormuz turning away even Chinese vessels, there’s no telling when this resolves.

SKYX Platforms (SKYX) – Tempered Near-Term Outlook, Long-Term Scaling Remains


Friday, March 27, 2026

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Q4 results. SKYX reported revenue of $24.9M versus our $26.5M estimate, reflecting a modest miss tied to the delayed rollout of the SKYFAN & Turbo Heater and disruption from its new AI-driven e-commerce platform. Adj. EBITDA loss of $2.7M was worse than our expectation of a loss of $0.4M.

Near-term catalysts. The SKYFAN & Turbo Heater has launched across major retailers, and we expect broader distribution and SKU expansion to support growth through 2026. The new AI-driven platform should improve conversion across the company’s owned websites following near-term disruption.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Newsmax (NMAX) – Among The Few Media Growth Companies


Friday, March 27, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Exceeds Q4 results. Newsmax delivered solid fourth quarter results with total revenue of $52.2 million, representing a 9.6% year-over-year increase, driven primarily by growth in broadcasting revenue, particularly affiliate fees and linear advertising demand. Importantly, profitability trends improved meaningfully, with adjusted EBITDA outperforming expectations, reflecting early signs of operating leverage despite continued investment in content and infrastructure.

Quarter Highlights: The quarter was characterized by strong execution across key operating metrics, including robust affiliate fee growth (+17.9%), continued resilience in advertising revenue, and significant audience expansion across both linear and streaming platforms. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Google’s Memory Efficiency Breakthrough Sends Chip Stocks Tumbling — But Is the Market Overreacting?

Memory chip stocks took a beating Thursday after Google went public with research on a new algorithm that could dramatically reduce the amount of memory needed to run large language models — rattling a sector that had been riding an AI-fueled supply crunch straight up.

Samsung Electronics and SK Hynix, the South Korean heavyweights that dominate the high-bandwidth memory market, both fell at least 6% in Seoul trading. In the U.S., Micron Technology (MU) slid more than 7%, while Western Digital and Sandisk each dropped at least 5%. Nvidia (NVDA) was not spared either, shedding nearly 4% as broader AI infrastructure sentiment soured.

What Google Actually Did

Google’s TurboQuant algorithm, which the company publicized on X this week — though the underlying research originally surfaced last year — claims to cut the memory required to run large language models by at least a factor of six. The efficiency gain targets what’s known as the key value cache, a critical bottleneck in AI inference, or the process of running AI models to generate outputs.

If widely adopted, TurboQuant could reduce the memory footprint of AI workloads significantly, theoretically easing the supply crunch that has sent chip prices and margins soaring across the sector.

The Bull Case Didn’t Disappear Overnight

Context matters here. Memory chip stocks had been on an extraordinary run. SK Hynix and Samsung shares had each surged more than 50% year-to-date through Wednesday, fueled by insatiable demand from hyperscalers building out AI infrastructure at historic scale. SK Group Chairman Chey Tae-won as recently as this week said the memory chip shortage would persist through 2030.

Morgan Stanley analyst Shawn Kim pushed back on the panic in a note, arguing the impact of Google’s research should ultimately be net positive for the industry. His logic: if AI models can run with materially lower memory requirements without sacrificing performance, the cost per query drops, making AI deployment more profitable and accelerating adoption — which in turn drives more demand for memory, not less.

Kim and analysts at JPMorgan and Citigroup all invoked the Jevons Paradox — a 19th century economic concept holding that greater efficiency in resource use tends to increase total consumption rather than reduce it. The same argument made the rounds when DeepSeek’s low-cost AI model rattled markets last year.

The Bigger Picture for Investors

The four largest hyperscalers — led by Amazon and Google — are collectively on track to spend roughly $650 billion this year on data center infrastructure. That spending appetite doesn’t evaporate because of one efficiency algorithm, and Ortus Advisors analyst Andrew Jackson noted the Google development may make little practical difference to near-term demand given how constrained supply remains.

For small and microcap investors with exposure to the memory supply chain — component manufacturers, equipment makers, or specialty materials companies — Thursday’s selloff may be more noise than signal. The structural demand drivers behind AI infrastructure spending remain firmly intact.

The more pressing question isn’t whether TurboQuant reduces memory demand. It’s whether the market had already priced in perfection for a sector where any efficiency headline is now treated as an existential threat.